US Patent 9539200 Two-piece, internal-channel osmotic delivery system flow modulator
Patent 9539200 was granted and assigned to Intarcia Therapeutics, Inc. on January, 2017 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 9539200 Two-piece, internal-channel osmotic delivery system flow modulator
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
